HIV infection or HAART therapy: what is the cause of adverse obstetric outcomes

HIV infection or HAART therapy: what is the cause of adverse obstetric outcomes Arch Gynecol Obstet (2017) 296:607–608 DOI 10.1007/s00404-017-4416-7 CO RRESP ON DENC E HIV infection or HAART therapy: what is the cause of adverse obstetric outcomes 1 2 3 • • Mauro Cozzolino Nicola Cozzolino Nadia Scotti Received: 10 April 2017 / Accepted: 30 May 2017 / Published online: 7 June 2017 Springer-Verlag GmbH Germany 2017 Dear Editor, controlled HIV infection a real risk of adverse for obstetric outcomes? I really enjoyed Arab et al’s paper titled ‘‘Pregnancy out- In 2013, Briand et al. concluded that HIV-infected comes in HIV-patients women: a retrospective cohort women on antiretroviral therapy with low viral load can study’’ [1]. As the authors point out, HIV-positive women safely opt for vaginal delivery in the absence of obstetrical can continue actively to live for many years and to have a risk factors [4]. In Arab et al. study, did they include good quality of life. Nowadays, that is possible due to the patients with undetectable viral load? Futhermore, Authors Highly Active Antiretroviral Therapy (HAART) which has did not explain if C-sections were made as electives or been developed during the last decades. HAART can urgent. In the absence of these two characteristics, it was suppress viral http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Gynecology and Obstetrics Springer Journals

HIV infection or HAART therapy: what is the cause of adverse obstetric outcomes

Loading next page...
1
 
/lp/springer_journal/hiv-infection-or-haart-therapy-what-is-the-cause-of-adverse-obstetric-nYy52f0D00
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Gynecology; Obstetrics/Perinatology/Midwifery; Endocrinology; Human Genetics
ISSN
0932-0067
eISSN
1432-0711
D.O.I.
10.1007/s00404-017-4416-7
Publisher site
See Article on Publisher Site

Abstract

Arch Gynecol Obstet (2017) 296:607–608 DOI 10.1007/s00404-017-4416-7 CO RRESP ON DENC E HIV infection or HAART therapy: what is the cause of adverse obstetric outcomes 1 2 3 • • Mauro Cozzolino Nicola Cozzolino Nadia Scotti Received: 10 April 2017 / Accepted: 30 May 2017 / Published online: 7 June 2017 Springer-Verlag GmbH Germany 2017 Dear Editor, controlled HIV infection a real risk of adverse for obstetric outcomes? I really enjoyed Arab et al’s paper titled ‘‘Pregnancy out- In 2013, Briand et al. concluded that HIV-infected comes in HIV-patients women: a retrospective cohort women on antiretroviral therapy with low viral load can study’’ [1]. As the authors point out, HIV-positive women safely opt for vaginal delivery in the absence of obstetrical can continue actively to live for many years and to have a risk factors [4]. In Arab et al. study, did they include good quality of life. Nowadays, that is possible due to the patients with undetectable viral load? Futhermore, Authors Highly Active Antiretroviral Therapy (HAART) which has did not explain if C-sections were made as electives or been developed during the last decades. HAART can urgent. In the absence of these two characteristics, it was suppress viral

Journal

Archives of Gynecology and ObstetricsSpringer Journals

Published: Jun 7, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off